Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
<Group xmlns="http://hl7.org/fhir">
<id value="236776"/>
<meta>
<versionId value="60"/>
<lastUpdated value="2024-10-03T13:11:20.368Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-definition"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Group 236776</b></p><a name="236776"> </a><a name="hc236776"> </a><a name="236776-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 60; Last updated: 2024-10-03 13:11:20+0000</p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-exposure-definition.html">ExposureDefinition</a></p></div><p><b>Artifact Author</b>: Computable Publishing®: MAGIC-to-FEvIR Converter: </p><p><b>Artifact related artifact</b>: No display for RelatedArtifact (type: part-of; resourceReference: ->display: string (PrimitiveType/Group.extension[1].value[x].resourceReference.display): element = string -> display=string[MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes])</p><p><b>Artifact Title</b>: ComparatorDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists</p><p><b>Artifact URL</b>: <a href="https://fevir.net/resources/Group/236776">https://fevir.net/resources/Group/236776</a></p><p><b>Artifact Publisher</b>: Computable Publishing LLC</p><p><b>Artifact Copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>
</div><p><b>Artifact use context</b>: <span title="{https://fevir.net/resources/CodeSystem/179423 evidence-communication}">Evidence Communication</span> = <span title="Codes:{https://fevir.net/resources/CodeSystem/179423 ExposureDefinition}">ExposureDefinition</span></p><p><b>Artifact Contact</b>: <a href="mailto:support@computablepublishing.com">support@computablepublishing.com</a></p><p><b>Artifact Status</b>: active</p><p><b>identifier</b>: FEvIR Object Identifier/236776, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-comparator-85394-C-85798</p><p><b>name</b>: Glucagon_Like_Peptide_1_GLP_1_receptor_agonists85394_C_85798</p><p><b>description</b>: </p><div><p>This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>
</div><p><b>type</b>: Animal</p><p><b>membership</b>: Definitional</p></div>
</text>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
<valueContactDetail>
<name value="Computable Publishing®: MAGIC-to-FEvIR Converter"/>
</valueContactDetail>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact">
<valueRelatedArtifact>
<type value="part-of"/>
<resourceReference>
<type value="Composition"/>
<identifier>
<type>
<text value="FEvIR Linking Identifier"/>
</type>
<system value="https://fevir.net/FLI"/>
<value value="MAGIC-5288-j1Wqrn-conversion-report"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<display
value="MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes"/>
</resourceReference>
</valueRelatedArtifact>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-title">
<valueString
value="ComparatorDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists"/>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-url">
<valueUri value="https://fevir.net/resources/Group/236776"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-publisher">
<valueString value="Computable Publishing LLC"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-copyright">
<valueMarkdown
value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/artifact-useContext">
<valueUsageContext>
<code>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="evidence-communication"/>
<display value="Evidence Communication"/>
</code>
<valueCodeableConcept>
<coding>
<system value="https://fevir.net/resources/CodeSystem/179423"/>
<code value="ExposureDefinition"/>
<display value="ExposureDefinition"/>
</coding>
</valueCodeableConcept>
</valueUsageContext>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/artifact-contact">
<valueContactDetail>
<telecom>
<system value="email"/>
<value value="support@computablepublishing.com"/>
</telecom>
</valueContactDetail>
</extension>
<modifierExtension
url="http://hl7.org/fhir/StructureDefinition/artifact-status">
<valueCode value="active"/>
</modifierExtension>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="236776"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<identifier>
<type>
<text value="FEvIR Linking Identifier"/>
</type>
<system value="https://fevir.net/FLI"/>
<value value="MAGIC-5288-j1Wqrn-comparator-85394-C-85798"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<name value="Glucagon_Like_Peptide_1_GLP_1_receptor_agonists85394_C_85798"/>
<description
value="This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide."/>
<type value="animal"/>
<membership value="definitional"/>
</Group>